Davictrel (etanercept biosimilar) / Hanwha Solutions, Merck (MSD)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Davictrel (etanercept biosimilar) / Hanwha Solutions
NCT01270997: Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients

Checkmark EULAR 2014 [HERA study]
May 2014 - May 2014: EULAR 2014 [HERA study]
Completed
3
294
RoW
Etanercept, HD203, Enbrel
Hanwha Chemical
Rheumatoid Arthritis
05/12
05/12

Download Options